US 9326992
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
granted A61KA61K31/713A61K47/6455
Quick answer
US patent 9326992 (Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 86
- CPC classes
- A61K, A61K31/713, A61K47/6455, A61P, A61P43/00